Agios licenses Oscotec drug; CEPI funds three potential Ebola vaccinesnews2026-06-01T14:39:37+00:00June 1st, 2026|Endpoints News|
#ASCO26: Kelonia Therapeutics delivers an impressive in vivo CAR-T updatenews2026-06-01T14:29:34+00:00June 1st, 2026|Endpoints News|
After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listingnews2026-06-01T14:11:13+00:00June 1st, 2026|Endpoints News|
Turn Therapeutics’ eczema drug shows rapid response in mid-stage datanews2026-06-01T12:51:57+00:00June 1st, 2026|Endpoints News|
Servier signs $1.55B upfront deal for Edgewise’s muscular dystrophy assetsnews2026-06-01T12:31:49+00:00June 1st, 2026|Endpoints News|
